{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:25:50Z","timestamp":1773660350115,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41440-021-00630-4","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T02:02:56Z","timestamp":1613959376000},"page":"791-802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats"],"prefix":"10.1038","volume":"44","author":[{"given":"Julieta S.","family":"Del Mauro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula D.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanina","family":"Santander Plantamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Allo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Parola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahuel","family":"Fernandez Machulsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela A.","family":"Morett\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana P.","family":"Bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n E.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Facundo M.","family":"Bertera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carranza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego A.","family":"Chiappetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel H.","family":"Polizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"H\u00f6cht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"630_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0002-9343(76)90904-9","volume":"60","author":"P Lewis","year":"1976","unstructured":"Lewis P. The essential action of propranolol in hypertension. Am J Med. 1976;60:837\u201352.","journal-title":"Am J Med"},{"key":"630_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507\u201320.","journal-title":"JAMA."},{"key":"630_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36:2284\u2013309.","journal-title":"J Hypertens"},{"key":"630_CR4","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/eurheartj\/ehz681","volume":"40","author":"T McCormack","year":"2019","unstructured":"McCormack T, Boffa RJ, Jones NR, Carville S, McManus RJ. The 2018 ESC\/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ. Eur Heart J. 2019;40:3456\u201358.","journal-title":"Eur Heart J"},{"key":"630_CR5","first-page":"CD002003","volume":"1","author":"CS Wiysonge","year":"2017","unstructured":"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017;1:CD002003.","journal-title":"Cochrane Database Syst Rev"},{"key":"630_CR6","doi-asserted-by":"publisher","first-page":"e1921618","DOI":"10.1001\/jamanetworkopen.2019.21618","volume":"3","author":"J Wei","year":"2020","unstructured":"Wei J, Galaviz KI, Kowalski AJ, Magee MJ, Haw JS, Narayan KMV, et al. Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis. JAMA Netw Open. 2020;3:e1921618.","journal-title":"JAMA Netw Open"},{"key":"630_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahl\u00f6f","year":"2005","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOTBPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895\u2013906.","journal-title":"Lancet."},{"key":"630_CR8","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","volume":"113","author":"B Williams","year":"2006","unstructured":"Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213\u201325.","journal-title":"Circulation."},{"key":"630_CR9","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.2174\/1381612823666170608085109","volume":"23","author":"C H\u00f6cht","year":"2017","unstructured":"H\u00f6cht C, Bertera FM, Del Mauro JS, Santander Plantamura Y, Taira CA, Polizio AH. What is the real efficacy of beta-blockers for the treatment of essential hypertension? Curr Pharm Des. 2017;23:4658\u201377.","journal-title":"Curr Pharm Des"},{"key":"630_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","volume":"9","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahl\u00f6f B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469\u201380.","journal-title":"Lancet Neurol"},{"key":"630_CR11","doi-asserted-by":"publisher","first-page":"104587","DOI":"10.1016\/j.phrs.2019.104587","volume":"151","author":"C Fumagalli","year":"2020","unstructured":"Fumagalli C, Maurizi N, Marchionni N, Fornasari D. \u03b2-blockers: Their new life from hypertension to cancer and migraine. Pharm Res. 2020;151:104587.","journal-title":"Pharm Res"},{"key":"630_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/HJH.0000000000002334","volume":"38","author":"R Del Pinto","year":"2020","unstructured":"Del Pinto R, Ferri C, Parati G. Reduction of blood pressure variability: an additional protective cardiovascular effect of vasodilating beta-blockers? J Hypertens. 2020;38:405\u20137.","journal-title":"J Hypertens"},{"key":"630_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41440-018-0194-2","volume":"42","author":"C Loutradis","year":"2019","unstructured":"Loutradis C, Bikos A, Raptis V, Afkou Z, Tzanis G, Pyrgidis N, et al. Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension. Hypertens Res. 2019;42:1001\u201310.","journal-title":"Hypertens Res"},{"key":"630_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.recesp.2019.02.023","volume":"72","author":"E Oliver","year":"2019","unstructured":"Oliver E, Mayor F Jr, D\u2019Ocon P. Beta-blockers: Historical Perspective and Mechanisms of Action. Rev Esp Cardiol. 2019;72:853\u201362.","journal-title":"Rev Esp Cardiol"},{"key":"630_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/HJH.0000000000002284","volume":"38","author":"JS Del Mauro","year":"2020","unstructured":"Del Mauro JS, Prince PD, Allo MA, Santander Plantamura Y, Morett\u00f3n MA, Gonz\u00e1lez GE, et al. Effects of third-generation \u03b2-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats. J Hypertens. 2020;38:536\u201345.","journal-title":"J Hypertens"},{"key":"630_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/hr.2013.140","volume":"37","author":"FM Bertera","year":"2014","unstructured":"Bertera FM, Del Mauro JS, Lovera V, Chiappetta D, Polizio AH, Taira CA, et al. Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats. Hypertens Res. 2014;37:194\u2013201.","journal-title":"Hypertens Res."},{"key":"630_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jash.2017.02.007","volume":"11","author":"JS Del Mauro","year":"2017","unstructured":"Del Mauro JS, Prince PD, Donato M, Fernandez Machulsky N, Morett\u00f3n MA, Gonz\u00e1lez GE, et al. Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability. J Am Soc Hypertens. 2017;11:227\u201340.","journal-title":"J Am Soc Hypertens"},{"key":"630_CR18","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1097\/HJH.0b013e328356766f","volume":"30","author":"J Varagic","year":"2012","unstructured":"Varagic J, Ahmad S, Voncannon JL, Moniwa N, Simington SW Jr, Brosnihan BK, et al. Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats. J Hypertens. 2012;30:1766\u201374.","journal-title":"J Hypertens"},{"key":"630_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00004872-200203000-00017","volume":"20","author":"F Cosentino","year":"2002","unstructured":"Cosentino F, Bonetti S, Rehorik R, Eto M, Werner-Felmayer G, Volpe M, et al. Nitric-oxide mediated relaxations in salt-induced hypertension: effect of chronic beta1-selective receptor blockade. J Hypertens. 2002;20:421\u20138.","journal-title":"J Hypertens"},{"key":"630_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/10641963.2017.1306539","volume":"39","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang F, Liu Y, Yin S, Pang X, Li Z, et al. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats. Clin Exp Hypertens. 2017;39:628\u201339.","journal-title":"Clin Exp Hypertens"},{"key":"630_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1472-8206.2004.00200.x","volume":"18","author":"LP Xu","year":"2004","unstructured":"Xu LP, Shen FM, Shu H, Miao CY, Jiang YY, Su DF. Synergism of atenolol and amlodipine on lowering and stabilizing blood pressure in spontaneously hypertensive rats. Fundam Clin Pharm. 2004;18:33\u201338.","journal-title":"Fundam Clin Pharm"},{"key":"630_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1161\/01.HYP.0000150857.39919.cb","volume":"45","author":"TW Kurtz","year":"2005","unstructured":"Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension. 2005;45:299\u2013310.","journal-title":"Hypertension."},{"key":"630_CR23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1203\/01.PDR.0000127012.37315.36","volume":"55","author":"P Pladys","year":"2004","unstructured":"Pladys P, Lahaie I, Cambonie G, Thibault G, L\u00ea NL, Abran D, et al. Role of brain and peripheral angiotensin II in hypertension and altered arterial baroreflex programmed during fetal life in rat. Pediatr Res. 2004;55:1042\u20139.","journal-title":"Pediatr Res"},{"key":"630_CR24","doi-asserted-by":"publisher","first-page":"H1321","DOI":"10.1152\/ajpheart.00874.2006","volume":"292","author":"AM Langager","year":"2007","unstructured":"Langager AM, Hammerberg BE, Rotella DL, Stauss HM. Very low-frequency blood pressure variability depends on voltage-gated L-type Ca2+ channels in conscious rats. Am J Physiol Heart Circ Physiol. 2007;292:H1321\u2013H1327.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"630_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11906-015-0597-2","volume":"17","author":"IM Salman","year":"2015","unstructured":"Salman IM. Current approaches to quantifying tonic and reflex autonomic outflows controlling cardiovascular function in humans and experimental animals. Curr Hypertens Rep. 2015;17:84.","journal-title":"Curr Hypertens Rep."},{"key":"630_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358\u201367.","journal-title":"J Am Soc Echocardiogr"},{"key":"630_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.carpath.2016.01.004","volume":"25","author":"GE Gonz\u00e1lez","year":"2016","unstructured":"Gonz\u00e1lez GE, Wilensky L, Cassaglia P, Morales C, Gelpi RJ. Early administration of enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction. Cardiovasc Pathol. 2016;25:208\u201313.","journal-title":"Cardiovasc Pathol"},{"key":"630_CR28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/00005344-200309000-00005","volume":"42","author":"E Guerrero","year":"2003","unstructured":"Guerrero E, Voces F, Ardanaz N, Montero MJ, Ar\u00e9valo M, Sevilla MA. Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats. J Cardiovasc Pharm. 2003;42:348\u201355.","journal-title":"J Cardiovasc Pharm"},{"key":"630_CR29","doi-asserted-by":"publisher","first-page":"812160","DOI":"10.1093\/ecam\/neq063","volume":"2011","author":"X Xiong","year":"2011","unstructured":"Xiong X, You C, Feng QC, Yin T, Chen ZB, Ball P, et al. Pulse width modulation electro-acupuncture on cardiovascular remodelling and plasma nitric oxide in spontaneously hypertensive rats. Evid Based Complement Altern Med. 2011;2011:812160.","journal-title":"Evid Based Complement Altern Med"},{"key":"630_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1440-1681.2005.04229.x","volume":"32","author":"DS Wang","year":"2005","unstructured":"Wang DS, Xie HH, Shen FM, Cai GJ, Su DF. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Clin Exp Pharm Physiol. 2005;32:545\u201352.","journal-title":"Clin Exp Pharm Physiol"},{"key":"630_CR31","doi-asserted-by":"publisher","first-page":"e14183","DOI":"10.14814\/phy2.14183","volume":"7","author":"LI Zambrano","year":"2019","unstructured":"Zambrano LI, Pontes RB, Garcia ML, Nishi EE, Nogueira FN, Higa EMS, et al. Pattern of sympathetic vasomotor activity in a model of hypertension induced by nitric oxide synthase blockade. Physiol Rep. 2019;7:e14183.","journal-title":"Physiol Rep"},{"key":"630_CR32","doi-asserted-by":"publisher","first-page":"117915","DOI":"10.1016\/j.lfs.2020.117915","volume":"256","author":"GL Cavalcante","year":"2020","unstructured":"Cavalcante GL, Ferreira FN, da Silva MTB, Soriano RN, ALMM Filho, DDR Arcanjo, et al. Acetylcholinesterase inhibition prevents alterations in cardiovascular autonomic control and gastric motility in L-NAME-induced hypertensive rats. Life Sci. 2020;256:117915.","journal-title":"Life Sci"},{"key":"630_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41440-020-0421-5","volume":"43","author":"G Parati","year":"2020","unstructured":"Parati G, Torlasco C, Pengo M, Bilo G, Ochoa JE. Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases. Hypertens Res. 2020;43:609\u201320.","journal-title":"Hypertens Res"},{"key":"630_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fphys.2015.00368","volume":"6","author":"C Bouissou-Schurtz","year":"2015","unstructured":"Bouissou-Schurtz C, Lindesay G, Regnault V, Renet S, Safar ME, Molinie V, et al. Development of an experimental model to study the relationship between day-to-day variability in blood pressure and aortic stiffness. Front Physiol. 2015;6:368.","journal-title":"Front Physiol"},{"key":"630_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrcardio.2013.1","volume":"10","author":"G Parati","year":"2013","unstructured":"Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10:143\u201355.","journal-title":"Nat Rev Cardiol."},{"key":"630_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1440-1681.2007.04588.x","volume":"34","author":"HM Stauss","year":"2007","unstructured":"Stauss HM. Identification of blood pressure control mechanisms by power spectral analysis. Clin Exp Pharmacol Physiol. 2007;34:362\u201388.","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"630_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1254\/jjp.29.171","volume":"29","author":"K Takeda","year":"1979","unstructured":"Takeda K, Nakagawa Y, Hashimoto T, Sakurai H, Imai S. Effects of several beta-blocking agents on the development of hypertension in spontaneously hypertensive rats. Jpn J Pharm. 1979;29:171\u20138.","journal-title":"Jpn J Pharm"},{"key":"630_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0021-5198(19)52693-2","volume":"32","author":"K Takeda","year":"1982","unstructured":"Takeda K, Nakagawa Y, Chin WP, Imai S. A comparison of antihypertensive effects of atenolol and propranolol in the spontaneously hypertensive, DOCA\/saline hypertensive and renal hypertensive rats. Jpn J Pharm. 1982;32:283\u20139.","journal-title":"Jpn J Pharm"},{"key":"630_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.lfs.2007.06.003","volume":"81","author":"T Horinouchi","year":"2007","unstructured":"Horinouchi T, Morishima S, Tanaka T, Suzuki F, Tanaka Y, Koike K, et al. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life Sci. 2007;81:399\u2013404.","journal-title":"Life Sci"},{"key":"630_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1469-7793.2000.t01-1-00263.x","volume":"525","author":"IB Wilkinson","year":"2000","unstructured":"Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525:263\u201370.","journal-title":"J Physiol"},{"key":"630_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/01.HYP.0000137983.45556.6e","volume":"44","author":"CM McEniery","year":"2004","unstructured":"McEniery CM, Schmitt M, Qasem A, Webb DJ, Avolio AP, Wilkinson IB, et al. Nebivolol increases arterial distensibility in vivo. Hypertension. 2004;44:305\u201310.","journal-title":"Hypertension."},{"key":"630_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/HJH.0000000000000024","volume":"32","author":"M Bordicchia","year":"2014","unstructured":"Bordicchia M, Pocognoli A, D\u2019Anzeo M, Siquini W, Minardi D, Muzzonigro G, et al. Nebivolol induces, via \u03b23 adrenergic receptor, lipolysis, uncoupling protein 1, and reduction of lipid droplet size in human adipocytes. J Hypertens. 2014;32:389\u201396.","journal-title":"J Hypertens"},{"key":"630_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/01.hjh.0000198035.16634.c1","volume":"24","author":"EI Guerrero","year":"2006","unstructured":"Guerrero EI, Ardanaz N, Sevilla MA, Ar\u00e9valo MA, Montero MJ. Cardiovascular effects of nebivolol in spontaneously hypertensive rats persist after treatment withdrawal. J Hypertens. 2006;24:151\u20138.","journal-title":"J Hypertens"},{"key":"630_CR44","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ehf2.12306","volume":"5","author":"AC Pouleur","year":"2018","unstructured":"Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, et al. Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH). ESC Heart Fail. 2018;5:830\u201341.","journal-title":"ESC Heart Fail"},{"key":"630_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep41865","volume":"7","author":"JL Miguel-Carrasco","year":"2017","unstructured":"Miguel-Carrasco JL, Beaumont J, San Jos\u00e9 G, Moreno MU, L\u00f3pez B, Gonz\u00e1lez A, et al. Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites. Sci Rep. 2017;7:41865.","journal-title":"Sci Rep"},{"key":"630_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00005344-200202000-00006","volume":"39","author":"SR Pacca","year":"2002","unstructured":"Pacca SR, de Azevedo AP, De Oliveira CF, De Luca IM, De Nucci G, Antunes E. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. J Cardiovasc Pharm. 2002;39:201\u20137.","journal-title":"J Cardiovasc Pharm"},{"key":"630_CR47","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1097\/HJH.0b013e3282efeecb","volume":"25","author":"MJ Pires","year":"2007","unstructured":"Pires MJ, Rodr\u00edguez-Pe\u00f1a AB, Ar\u00e9valo M, Cenador B, Evangelista S, Esteller A, et al. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction. J Hypertens. 2007;25:2486\u201396.","journal-title":"J Hypertens"},{"key":"630_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2014.03.026","volume":"734","author":"JF Ndisang","year":"2014","unstructured":"Ndisang JF, Chibbar R, Lane N. Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension. Eur J Pharm. 2014;734:23\u201334.","journal-title":"Eur J Pharm"},{"key":"630_CR49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","volume":"14","author":"ZG Ma","year":"2018","unstructured":"Ma ZG, Yuan YP, Wu HM, Zhang X, Tang QZ. Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci. 2018;14:1645\u201357.","journal-title":"Int J Biol Sci"},{"key":"630_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","volume":"56","author":"GC Mel\u00e9ndez","year":"2010","unstructured":"Mel\u00e9ndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension. 2010;56:225\u201331.","journal-title":"Hypertension."},{"key":"630_CR51","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1039\/C8FO02408A","volume":"10","author":"P Potue","year":"2019","unstructured":"Potue P, Wunpathe C, Maneesai P, Kukongviriyapan U, Prachaney P, Pakdeechote P. Nobiletin alleviates vascular alterations through modulation of Nrf-2\/HO-1 and MMP pathways in l-NAME induced hypertensive rats. Food Funct. 2019;10:1880\u201392.","journal-title":"Food Funct"},{"key":"630_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2013.06.033","volume":"65","author":"CS Ceron","year":"2013","unstructured":"Ceron CS, Rizzi E, Guimar\u00e3es DA, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-\u03b2 and MMPs, and decreases vascular remodeling in renovascular hypertension. Free Radic Biol Med. 2013;65:47\u201356.","journal-title":"Free Radic Biol Med"},{"key":"630_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2019.01.010","volume":"99","author":"R Chen","year":"2019","unstructured":"Chen R, Sun Y, Cui X, Ji Z, Kong X, Wu S, et al. Autophagy promotes aortic adventitial fibrosis via the IL-6\/Jak1 signaling pathway in Takayasu\u2019s arteritis. J Autoimmun. 2019;99:39\u201347.","journal-title":"J Autoimmun"},{"key":"630_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/01.HYP.16.1.12","volume":"16","author":"JL Reid","year":"1990","unstructured":"Reid JL, Meredith PA. Concentration-effect analysis of antihypertensive drug responses. Hypertension. 1990;16:12\u20138.","journal-title":"Hypertension."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00630-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00630-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00630-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T17:11:45Z","timestamp":1666977105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-021-00630-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1038\/s41440-021-00630-4","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"2 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}